Welcome to the InfoSci Platform
Innovation Diffusion Among Heterogeneous Agents: Exploring Complexity with Agent-Based Modelling (ABM)

Innovation Diffusion Among Heterogeneous Agents: Exploring Complexity with Agent-Based Modelling (ABM)

Nazmun N. Ratna, Anne Dray, Pascal Perez, R. Quentin Grafton, Tom Kompas
Copyright: © 2008 |Pages: 29
ISBN13: 9781599049625|ISBN10: 1599049627|EISBN13: 9781599049632
DOI: 10.4018/978-1-59904-962-5.ch005
Cite Chapter Cite Chapter

MLA

Ratna, Nazmun N., et al. "Innovation Diffusion Among Heterogeneous Agents: Exploring Complexity with Agent-Based Modelling (ABM)." Applications of Complex Adaptive Systems, edited by Yin Shan and Ang Yang, IGI Global, 2008, pp. 113-141. https://doi.org/10.4018/978-1-59904-962-5.ch005

APA

Ratna, N. N., Dray, A., Perez, P., Grafton, R. Q., & Kompas, T. (2008). Innovation Diffusion Among Heterogeneous Agents: Exploring Complexity with Agent-Based Modelling (ABM). In Y. Shan & A. Yang (Eds.), Applications of Complex Adaptive Systems (pp. 113-141). IGI Global. https://doi.org/10.4018/978-1-59904-962-5.ch005

Chicago

Ratna, Nazmun N., et al. "Innovation Diffusion Among Heterogeneous Agents: Exploring Complexity with Agent-Based Modelling (ABM)." In Applications of Complex Adaptive Systems, edited by Yin Shan and Ang Yang, 113-141. Hershey, PA: IGI Global, 2008. https://doi.org/10.4018/978-1-59904-962-5.ch005

Export Reference

Mendeley
Favorite

Abstract

In this paper we apply Agent-Based Modelling (ABM) to capture the complexity of the diffusion process depicted in Medical Innovation, the classic study on diffusion of a new drug Tetracycline by (Coleman, Katz, & Menzel, 1966). Based on our previous model with homogenous social agents, Gammanym (Ratna, Dray, Perez, Grafton, Newth, & Kompas, 2007), in this paper we further our analysis with heterogenous social agents who vary in terms of their degree of predisposition to knowledge. We also explore the impact of stage-dependent degrees of external influence from the change agent, pharmaceutical company in this case. Cumulative diffusion curves suggest that the pharmaceutical company plays a much weaker role in accelerating the speed of diffusion when a diffusion dynamics is explored with complex agents, defined as heterogenous agents under stage-dependent degrees of external influence. Although our exploration with groups of doctors with different combination of social and professional integration signifies the importance of interpersonal ties, our analysis also reveals that degree of adoption threshold or individual predisposition to knowledge is crucial for adoption decisions. Overall, our approach brings in fresh insights to the burgeoning policy literature exploring complexity, by providing necessary framework for research translation to policy and practice.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.